p53 antibody orb11210 from Biorbyt

Product Specs
Itemp53 antibody
CompanyBiorbyt
Price Pricing Info Supplier Page
Catalog Numberorb11210
TargetP53 protein(wt-p53)
Quantity50 µl, 100 µl, 200 µl
Conjugate/TagUnconjugated
ApplicationsWB, ELISA, FCM, ICC, IF, IHC-fr, IHC-p
ReactivityHu, Ms, Rt
StorageShipped at 4°C. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles
NCBI Gene AliasesTRP53, BMFS5, P53, LFS1, BCC7
NCBI Full Gene Nametumor protein p53
Concentration1mg/ml
HostRabbit
IsotypeIgG
Molecular Weight43 kDa
ImmunogenKLH conjugated synthetic peptide derived from human P53 (251-310/393 aa)
FormatLiquid
ClonalityPolyclonal

Application Dilutions: WB=1:500-2000, IHC-P=1:100-500, ICC=1:100, Flow-Cyt=1µg/Test, IHC-F=1:100-500, IF=1:100-500, ELISA=1:5000-10000

7, Signet Court

Swann Road

Cambridge, Cambridgeshire CB5 8LA

United Kingdom

Phone: +44(0)1223 815 212
+44(0)1223 280 240 (fax)
+44(0)1223 280 240

Email: info@biorbyt.com
support@biorbyt.com
accounts@biorbyt.com

(1) Effects of Long-Term Exposure to Copper on Mitochondria-Mediated Apoptosis in Pig LiverBiological trace element researchApril 1, 2023Hu Z, Liao J, Zhang K, Huang K, Li Q, Lei C, Han Q, Zhang H, Guo J, Hu L, et al.

(2) Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinomaBioFactors (Oxford, England)July 1, 2020Liu F, Pan Q, Wang L, Yi S, Liu P, Huang W.

(3) Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcomaBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieJune 1, 2020Tan J, Qin X, Liu B, Mo H, Wu Z, Yuan Z.

(4) Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancerJournal of cancer research and clinical oncologyApril 1, 2020Muhammad T, Sakhawat A, Khan AA, Huang H, Khan HR, Huang Y, Wang J.

(7) To Be Or Not to Be: the “Smoker’s Paradox” – An in-Vitro StudyCellular Physiology and BiochemistryJanuary 1, 2018Franziska Wittmann, Adrian Türkcan, Ulrike Baranyi, Eva Eichmair, Günther Laufer, David Bernhard, Barbara Messner

(9) [Intra-abdominal pressure]Annales francaises d'anesthesie et de reanimationJanuary 1, 1994Carry PY, Banssillon V.

(10) Effective dose equivalent to the operator in intra-oral dental radiographyDento maxillo facial radiologyAugust 1, 1990de Haan RA, van Aken J.

(12) [Functional anatomy of the elbow joint]Der OrthopadeAugust 1, 1988Putz R, Müller-Gerbl M.

(14) Building or extending a hospital department: radiology. A path through the planning minefield (2)Journal of the Royal Society of MedicineFebruary 1, 1987Roebuck EJ, Manton DJ, Fordham GL.

(15) [The criteria for the termination of short-term tuberculosis chemotherapy]Taiwan yi xue hui za zhi. Journal of the Formosan Medical AssociationOctober 1, 1986Yang SP, Luh KT, Lin TP, Chang CE.

(16) The NHS needs a changeLancet (London, England)June 14, 1986

(17) Effect of interocclusal records on transverse axis positionThe Journal of prosthetic dentistrySeptember 1, 1985Jankelson B.

(18) [Liposome oxidation]Doklady Akademii nauk SSSRJanuary 1, 1984Zamorin OV.

(19) Putting the diluting effect into inclusive fitnessJournal of theoretical biologyJune 7, 1979Orlove MJ.

(20) [Rectal prolapse. Clinical studies on rectal prolapse]Der Chirurg; Zeitschrift fur alle Gebiete der operativen MedizenMarch 1, 1979Berk G.

p53 antibody